Dr. Samir Lewiz Habashi, MD

Dr. Habashi practices at Riverside Endoscopy Center in Jacksonville, Florida.

Dr. Habashi's NPI, 1043379738, was assigned on December 8, 2006. Dr. Habashi holds Florida license ME85362.

Dr. Habashi's primary practice is Riverside Endoscopy Center, at 2151 Riverside Ave, Jacksonville, FL 32204 in Duval County. The practice phone is (904) 388-8686.

Dr. Habashi's primary practice is Riverside Endoscopy Center in Jacksonville, Florida. Dr. Habashi is also affiliated with Ascension St. Vincent's Riverside. The medical group on file is Digestive Disease Consultants. Dmand AI also links Dr. Habashi to 5 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Habashi practices, 7 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Habashi's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Habashi is licensed in Florida.

CMS data shows 2,932 Medicare services from Dr. Habashi across 13 procedure codes in 2024, for 552 Medicare patients. Medicare paid $301,322 for them.

CMS counts 552 Medicare patients who saw Dr. Habashi in 2024. The largest group is 65 to 74, with 209 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 25% are also on Medicaid. Their average risk score is 2.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Habashi's median patient age at 61, with 57% women.

In 2024, Dr. Habashi wrote 1,290 Medicare Part D claims for 378 patients. 87% of them were for generic drugs. CMS names the drug for 1,099 of them, across 19 drugs with 11 or more claims each, at $490,289 in total drug cost. In 2023, CMS named 1,151 claims across 21 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Habashi for performance year 2024, reported individually. Dr. Habashi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 233 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Habashi, more than 92% of the clinicians it reports for that procedure.

Dmand AI links Dr. Habashi to 1 clinical trial. Conditions studied include Crohn Disease and Inflammatory Bowel Diseases. Open Payments lists research payments to Dr. Habashi that name 1 trial.

CMS Open Payments shows 320 general payments to Dr. Habashi from 25 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $2,634. It also lists 2 research payments totaling $11,363 from 2020 to 2021, naming 1 clinical trial.